Natixis Advisors LLC Sells 2,617 Shares of STERIS plc (NYSE:STE)

Natixis Advisors LLC lessened its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 1.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 147,995 shares of the medical equipment provider's stock after selling 2,617 shares during the quarter. Natixis Advisors LLC owned 0.15% of STERIS worth $30,422,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Human Investing LLC bought a new stake in STERIS during the 4th quarter valued at $31,000. Anfield Capital Management LLC boosted its holdings in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 91 shares during the last quarter. Central Pacific Bank Trust Division boosted its holdings in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 76 shares during the last quarter. Manchester Capital Management LLC boosted its holdings in STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after acquiring an additional 137 shares during the last quarter. Finally, Quarry LP purchased a new position in STERIS during the 3rd quarter worth $67,000. Institutional investors own 94.69% of the company's stock.

STERIS Stock Performance

STERIS stock traded up $0.21 during midday trading on Thursday, reaching $225.48. The stock had a trading volume of 524,059 shares, compared to its average volume of 501,726. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The firm's 50-day moving average price is $220.41 and its 200 day moving average price is $222.24. The firm has a market capitalization of $22.15 billion, a PE ratio of 47.87 and a beta of 0.92. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Thursday, February 20th. STERIS's dividend payout ratio is presently 48.41%.

Wall Street Analysts Forecast Growth

STE has been the topic of a number of research analyst reports. Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. JMP Securities reissued a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, Stephens reissued an "overweight" rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.